The International Terazosin Trial:A Multicentre Study of the Long-TermEfficacy and Safety of Terazosin in theTreatment of Benign ProstaticHyperplasia

F.M.J. Debruyne(Netherlands Aerospace Centre), Domenico Prezioso(Federico II University Hospital), Jennifer M. Fitzpatrick(University College Dublin), Wim P.J. Witjes(European Association of Urology), Roger Kirby(St George's Hospital), D. Kirk

European Urology

January 1, 1996

10.1159/000474198

Cited by 48

Related Papers

Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial

|European Urology|2018|577

Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group

|Archivio Italiano di Urologia e Andrologia|2015|202

Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpatients in Italy: Results of a Multicenter Case-Control Observational Study

|The Journal of Urology|2007|181

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

|European Urology|2020|132

Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas

|International Journal of Cancer|1999|97